Health Catalyst, Inc. HCAT
1.74
0.00
0.00%
as of 25 Sep
- Market cap
- $131.0M
- P/E
- 0.0×
Follow HCAT
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| P/E ratio | 0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
| P/S ratio | 0.50 | 0.30 | 0.54 | 0.63 | |
| P/FCF ratio | 22.35 | 0.00 | 0.00 | 0.00 | |
| P/Operating CF | 535.20 | 4.98 | 16.85 | (432.27) | |
| P/B ratio | 1.46 | 0.67 | 0.68 | 0.60 | |
| Price to Tangible BV | 4.38 | 0.00 | 0.00 | 0.00 | |
| EV/Sales | 0.67 | 0.45 | 0.72 | 0.83 | |
| EV/EBITDA | 22.32 | 11.39 | 62.48 | 0.00 | |
| EV/Operating CF | 6.99 | 7.21 | 307.21 | (20.63) | |
| EV/FCF | 29.95 | (50.38) | (10.81) | (7.83) | |
| Quick Ratio | 1.58 | 1.56 | 1.73 | 1.73 | |
| Current Ratio | 2.70 | 1.69 | 1.89 | 1.88 | |
| Net Debt/EBITDA | 24.21 | 25.14 | 6.34 | (15.11) | |
| Debt/Assets | 42.80% | 37.21% | 30.49% | 26.08% | |
| Debt/Equity | 1.52 | 1.11 | 0.62 | 0.46 | |
| Asset Turnover | 0.60 | 0.46 | 0.46 | 0.45 | |
| Operating CF/Net income | (0.01) | (0.17) | (0.11) | 0.02 | |
| Capex/Depreciation | (0.14) | (0.05) | (0.06) | (0.38) | |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | |
| Research and Development Expense of Revenue | 15.64% | 13.82% | 13.27% | 16.09% | |
| Selling, General and Administrative Expense of Revenue | 31.62% | 34.69% | 28.41% | 39.87% | |
| Intangible Assets out of Total Assets | 0.19 | 0.44 | 0.57 | 0.64 | |
| Share Based Compensation of Revenue | 3.84% | 5.33% | 5.50% | 9.22% | |
| Graham Net Nets | (0.06) | (1.00) | (0.52) | (0.45) | |
| Graham Number | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | (184.92%) | (292.91%) | (106.28%) | (55.79%) | |
| Free Cash Flow Yield | 4.47% | (2.94%) | (12.44%) | (16.68%) | |
| Revenue per Share | 0.95 | 0.97 | 1.07 | 1.08 | |
| Operating CF per Share | 0.00 | 0.26 | 0.14 | (0.01) | |
| Capex per Share | (0.07) | (0.08) | (0.08) | (0.07) | |
| Free Cash Flow per Share | (0.07) | 0.18 | 0.06 | (0.08) | |
| Cash per Share | 1.40 | 1.50 | 1.37 | 1.30 | |
| Shareholders Equity per Share | 1.36 | 1.90 | 3.52 | 4.72 | |
| Interest Debt per Share | 0.00 | 0.00 | 0.00 | 0.00 | |
| Book value per Share | 1.36 | 1.90 | 3.52 | 4.72 | |
| Free Cash Flow | (5.17) | 13.02 | 4.33 | (5.59) | |
| Working Capital | 156.47 | 74.70 | 79.73 | 77.46 | |
| Capital Expenditures | (5.45) | (5.49) | (5.58) | (5.13) | |
| Net Current Asset Value | (9.39) | (91.74) | (87.56) | (89.85) | |
| EV/EBIT | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capex to Sales | 0.08 | 0.08 | 0.07 | 0.07 | |
| Net Profit Margin | (57.51%) | (156.91%) | (121.89%) | (29.12%) | |
| Price to Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
| Average Receivables | 55.14 | 61.60 | 58.16 | 55.88 | |
| Average Payables | 8.64 | 10.32 | 10.40 | 9.61 | |
| Average Assets | 487.39 | 651.87 | 680.79 | 700.09 | |
| Average Common Equity | 224.19 | 257.48 | 305.49 | 343.48 |
Columns are period end dates